Functional consequences of 17q21.31/WNT3-WNT9B amplification in hPSCs with respect to neural differentiation

Cell Reports

Volumn 10, Issue 4, 2015, Pages 616-632

  Lee, Chun Ting ^a   Bendriem, Raphael M ^a   Kindberg, Abigail A ^a   Worden, Lila T ^a   Williams, Melanie P ^a   Drgon, Tomas ^a   Mallon, Barbara S ^b   Harvey, Brandon K ^a   Richie, Christopher T ^a   Hamilton, Rebecca S ^b   Chen, Jia ^a   Errico, Stacie L ^a   Tsai, Shang Yi A ^a   Uhl, George R ^a   Freed, William J ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; FIBROBLAST GROWTH FACTOR; STRESS ACTIVATED PROTEIN KINASE; WNT3 PROTEIN; WNT9B PROTEIN; WNT PROTEIN; WNT9B PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CHROMOSOME 17Q; CHROMOSOME 17Q21.31; CONTROLLED STUDY; COPY NUMBER VARIATION; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE CLUSTER; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; PHENOTYPIC VARIATION; PLURIPOTENT STEM CELL; WNT SIGNALING PATHWAY; WNT3 GENE; WNT9B GENE; CELL LINE; CYTOLOGY; GENETICS; METABOLISM; NERVE CELL; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; CELL LINE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; PLURIPOTENT STEM CELLS; SIGNAL TRANSDUCTION; WNT PROTEINS; WNT3 PROTEIN;

EID: 84922783350     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.12.050     Document Type: Article

References (31)

1. Baker D.E., Harrison N.J., Maltby E., Smith K., Moore H.D., Shaw P.J., Heath P.R., Holden H., Andrews P.W. Adaptation to culture of human embryonic stem cells and oncogenesis invivo. Nat. Biotechnol. 2007, 25:207-215.
2. Ben-David U., Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 2011, 11:268-277.
3. Ben-Yehudah A., Navara C.S., Redinger C.J., Mich-Basso J.D., Castro C.A., Oliver S., Chensny L.J., Richards T.J., Kaminski N., Schatten G. Pluripotency genes overexpressed in primate embryonic stem cells are localized on homologues of human chromosomes 16, 17, 19, and X. Stem Cell Res. (Amst.) 2010, 4:25-37.
4. Burbach J.P., Smidt M.P. Molecular programming of stem cells into mesodiencephalic dopaminergic neurons. Trends Neurosci. 2006, 29:601-603.
5. Cai J., Donaldson A., Yang M., German M.S., Enikolopov G., Iacovitti L. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model. Stem Cells 2009, 27:220-229.
6. Castelo-Branco G., Wagner J., Rodriguez F.J., Kele J., Sousa K., Rawal N., Pasolli H.A., Fuchs E., Kitajewski J., Arenas E. Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc. Natl. Acad. Sci. USA 2003, 100:12747-12752.
7. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ESand iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009, 27:275-280.
8. Chung S., Leung A., Han B.S., Chang M.Y., Moon J.I., Kim C.H., Hong S., Pruszak J., Isacson O., Kim K.S. Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway. Cell Stem Cell 2009, 5:646-658.
9. Ding V.M., Ling L., Natarajan S., Yap M.G., Cool S.M., Choo A.B. FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3beta signaling. J.Cell. Physiol. 2010, 225:417-428.
10. Ferri A.L., Lin W., Mavromatakis Y.E., Wang J.C., Sasaki H., Whitsett J.A., Ang S.L. Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development 2007, 134:2761-2769.
11. Girirajan S., Brkanac Z., Coe B.P., Baker C., Vives L., Vu T.H., Shafer N., Bernier R., Ferrero G.B., Silengo M., et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet. 2011, 7:e1002334.
12. Grisart B., Willatt L., Destrée A., Fryns J.P., Rack K., de Ravel T., Rosenfeld J., Vermeesch J.R., Verellen-Dumoulin C., Sandford R. 17q21.31 microduplication patients are characterised by behavioural problems and poor social interaction. J.Med. Genet. 2009, 46:524-530.
13. Guenther M.G., Frampton G.M., Soldner F., Hockemeyer D., Mitalipova M., Jaenisch R., Young R.A. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 2010, 7:249-257.
14. Karner C.M., Chirumamilla R., Aoki S., Igarashi P., Wallingford J.B., Carroll T.J. Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis. Nat. Genet. 2009, 41:793-799.
15. Kawano Y., Kypta R. Secreted antagonists of the Wnt signalling pathway. J.Cell Sci. 2003, 116:2627-2634.
16. Kim H., Lee G., Ganat Y., Papapetrou E.P., Lipchina I., Socci N.D., Sadelain M., Studer L. miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. Cell Stem Cell 2011, 8:695-706.
17. Krejci P., Aklian A., Kaucka M., Sevcikova E., Prochazkova J., Masek J.K., Mikolka P., Pospisilova T., Spoustova T., Weis M., et al. Receptor tyrosine kinases activate canonical WNT/β-catenin signaling via MAP kinase/LRP6 pathway and direct β-catenin phosphorylation. PLoS ONE 2012, 7:e35826.
18. Kriks S., Shim J.W., Piao J., Ganat Y.M., Wakeman D.R., Xie Z., Carrillo-Reid L., Auyeung G., Antonacci C., Buch A., et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011, 480:547-551.
19. Lie D.C., Colamarino S.A., Song H.J., Désiré L., Mira H., Consiglio A., Lein E.S., Jessberger S., Lansford H., Dearie A.R., Gage F.H. Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005, 437:1370-1375.
20. Mallon B.S., Chenoweth J.G., Johnson K.R., Hamilton R.S., Tesar P.J., Yavatkar A.S., Tyson L.J., Park K., Chen K.G., Fann Y.C., McKay R.D. StemCellDB: the human pluripotent stem cell database at the National Institutes of Health. Stem Cell Res. (Amst.) 2013, 10:57-66.
21. Mallon B.S., Hamilton R.S., Kozhich O.A., Johnson K.R., Fann Y.C., Rao M.S., Robey P.G. Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin. Stem Cell Res. (Amst.) 2014, 12:376-386.
22. McCarroll S.A., Kuruvilla F.G., Korn J.M., Cawley S., Nemesh J., Wysoker A., Shapero M.H., de Bakker P.I., Maller J.B., Kirby A., et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat. Genet. 2008, 40:1166-1174.
23. Närvä E., Autio R., Rahkonen N., Kong L., Harrison N., Kitsberg D., Borghese L., Itskovitz-Eldor J., Rasool O., Dvorak P., et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat. Biotechnol. 2010, 28:371-377.
24. Sato A., Yamamoto H., Sakane H., Koyama H., Kikuchi A. Wnt5a regulates distinct signalling pathways by binding to Frizzled2. EMBO J. 2010, 29:41-54.
25. Spencer C.C., Plagnol V., Strange A., Gardner M., Paisan-Ruiz C., Band G., Barker R.A., Bellenguez C., Bhatia K., Blackburn H., et al. Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum. Mol. Genet. 2011, 20:345-353. UK Parkinson's Disease Consortium, Wellcome Trust Case Control Consortium 2Wellcome Trust Case Control Consortium 2.
26. Tomoda K., Takahashi K., Leung K., Okada A., Narita M., Yamada N.A., Eilertson K.E., Tsang P., Baba S., White M.P., et al. Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell 2012, 11:91-99.
27. Topol L., Jiang X., Choi H., Garrett-Beal L., Carolan P.J., Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J.Cell Biol. 2003, 162:899-908.
28. Vazin T., Chen J., Spivak C.E., Amable R., Gabitzsch E., Lee C.T., Lupica C.R., Freed W.J. Dopaminergic neurons derived from BG01V2, a variant of human embryonic stem cell line BG01. Restor. Neurol. Neurosci. 2008, 26:447-458.
29. Werbowetski-Ogilvie T.E., Bossé M., Stewart M., Schnerch A., Ramos-Mejia V., Rouleau A., Wynder T., Smith M.J., Dingwall S., Carter T., et al. Characterization of human embryonic stem cells with features of neoplastic progression. Nat. Biotechnol. 2009, 27:91-97.
30. Yan Y., Yang D., Zarnowska E.D., Du Z., Werbel B., Valliere C., Pearce R.A., Thomson J.A., Zhang S.C. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 2005, 23:781-790.
31. Zhang F., Gu W., Hurles M.E., Lupski J.R. Copy number variation in human health, disease, and evolution. Annu. Rev. Genomics Hum. Genet. 2009, 10:451-481.